A detailed history of Xponance, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xponance, Inc. holds 322,569 shares of BMY stock, worth $18.6 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
322,569
Previous 317,381 1.63%
Holding current value
$18.6 Million
Previous $13.2 Million 26.65%
% of portfolio
0.16%
Previous 0.14%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $205,756 - $268,479
5,188 Added 1.63%
322,569 $16.7 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $1.03 Million - $1.35 Million
25,543 Added 8.75%
317,381 $13.2 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $689,424 - $781,673
14,369 Added 5.18%
291,838 $15.8 Million
Q4 2023

Jan 31, 2024

BUY
$48.48 - $57.85 $971,054 - $1.16 Million
20,030 Added 7.78%
277,469 $14.2 Million
Q3 2023

Oct 23, 2023

BUY
$57.89 - $64.73 $187,042 - $209,142
3,231 Added 1.27%
257,439 $14.9 Million
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $306,827 - $340,683
-4,816 Reduced 1.86%
254,208 $16.3 Million
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $350,168 - $397,170
5,329 Added 2.1%
259,024 $18 Million
Q4 2022

Jan 23, 2023

BUY
$68.48 - $81.09 $2.34 Million - $2.77 Million
34,161 Added 15.56%
253,695 $0
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $6,239 - $3.69 Million
47,993 Added 27.98%
219,534 $15.6 Million
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $1.83 Million - $2.02 Million
25,261 Added 17.27%
171,541 $13.2 Million
Q1 2022

Apr 20, 2022

BUY
$61.48 - $73.72 $116,689 - $139,920
1,898 Added 1.31%
146,280 $10.7 Million
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $1.44 Million - $1.68 Million
-26,888 Reduced 15.7%
144,382 $9 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $684,182 - $801,431
-11,563 Reduced 6.32%
171,270 $10.1 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $4.86 Million - $5.29 Million
-78,458 Reduced 30.03%
182,833 $12.2 Million
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $129,717 - $145,893
-2,186 Reduced 0.83%
261,291 $16.5 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $184,825 - $209,441
3,201 Added 1.23%
263,477 $16.3 Million
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $1.02 Million - $1.13 Million
-17,773 Reduced 6.39%
260,276 $15.7 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $15.2 Million - $17.8 Million
278,049 New
278,049 $16.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.